SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (1379)8/23/2005 12:33:09 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
COR Also opened with an upgap but found resistance at the 2.40 level at 11.39-11.44AM and is trying to find support at the 2,25 level without closing its upgap.<g>

There were some news today about a study by scientists from Wake Forest University, which have demonstrated in a primate model that the AMPAKINE® CX717, improved cognitive performance and also reversed the deleterious effects of sleep deprivation.

biz.yahoo.com

The stock is still up 8% while holding above 2.25 <g>

bigcharts.marketwatch.com

Bernard



To: Jibacoa who wrote (1379)8/24/2005 12:38:47 AM
From: Jibacoa  Respond to of 3722
 
OXGN Had a good upgap and was up 9.77% on expanding volume of 2,756,667 (higher than the 2,400,408 on April 6 )

bigcharts.marketwatch.com

The intraday H was 5.48 at 10.40AM and the stock was able to hold at the 5.21 level in the afternoon without closing the upgap in spite of the general market.(5.22 was the H on June 21)

It presented today at a meeting in Oxford.

biz.yahoo.com

The next hurdle is its February 14 H at 6.12

bigcharts.marketwatch.com

Bernard